These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34322158)

  • 41. Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective.
    Langmia IM; Just KS; Yamoune S; Müller JP; Stingl JC
    Br J Clin Pharmacol; 2022 Dec; 88(12):5149-5165. PubMed ID: 35863300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cyclophosphamide and CYP2B6].
    Torimoto Y; Kohgo Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1090-3. PubMed ID: 18633247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.
    Evans J; Swart M; Soko N; Wonkam A; Huzair F; Dandara C
    OMICS; 2015 Jun; 19(6):332-8. PubMed ID: 26415139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
    Božina N; Vrkić Kirhmajer M; Šimičević L; Ganoci L; Mirošević Skvrce N; Klarica Domjanović I; Merćep I
    Croat Med J; 2020 Apr; 61(2):147-158. PubMed ID: 32378381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inter-ethnic genetic variations and novel variant identification in the partial sequences of
    Ahmed S; Khan H; Khan A; Bangash MH; Hussain A; Qayum M; Hamdard MH
    PeerJ; 2021; 9():e11149. PubMed ID: 34386299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.
    di Iulio J; Fayet A; Arab-Alameddine M; Rotger M; Lubomirov R; Cavassini M; Furrer H; Günthard HF; Colombo S; Csajka C; Eap CB; Decosterd LA; Telenti A;
    Pharmacogenet Genomics; 2009 Apr; 19(4):300-9. PubMed ID: 19238117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in Methadone Metabolism by CYP2B6 Variants.
    Gadel S; Friedel C; Kharasch ED
    Drug Metab Dispos; 2015 Jul; 43(7):994-1001. PubMed ID: 25897175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
    Haas DW; Kwara A; Richardson DM; Baker P; Papageorgiou I; Acosta EP; Morse GD; Court MH
    J Antimicrob Chemother; 2014 Aug; 69(8):2175-82. PubMed ID: 24729586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
    Zhang H; Sridar C; Kenaan C; Amunugama H; Ballou DP; Hollenberg PF
    J Pharmacol Exp Ther; 2011 Sep; 338(3):803-9. PubMed ID: 21659470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
    Yuce-Artun N; Baskak B; Ozel-Kizil ET; Ozdemir H; Uckun Z; Devrimci-Ozguven H; Suzen HS
    Int J Clin Pharm; 2016 Apr; 38(2):388-94. PubMed ID: 26830411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models.
    Liang Z; Liu J; Huang JX; Zeng X
    Comb Chem High Throughput Screen; 2018; 21(2):93-99. PubMed ID: 29336255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
    Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
    Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use.
    Ramli FF
    Bosn J Basic Med Sci; 2021 Apr; 21(2):145-154. PubMed ID: 32841585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.
    Bienvenu E; Swart M; Dandara C; Ashton M
    Antiviral Res; 2014 Feb; 102():44-53. PubMed ID: 24316028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased prevalence of functional minor allele variants of drug metabolizing CYP2B6 and CYP2D6 genes in Roma population samples.
    Weber A; Szalai R; Sipeky C; Magyari L; Melegh M; Jaromi L; Matyas P; Duga B; Kovesdi E; Hadzsiev K; Melegh B
    Pharmacol Rep; 2015 Jun; 67(3):460-4. PubMed ID: 25933954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
    Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
    Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.